RE Royalties Announces Strategic Review to Evaluate Path for Long-Term Value Creation <!-- Twitter Tags --> <!-- Facebook Tags --> <!-- Injecting site-wide to the head --> <!-- End Injecting site-wide to the head --><!-- Inject secured cdn script --> <!-- ========= Meta Tags ========= --> <!-- PWA settings --> <!-- Add manifest --> <!-- End PWA settings --> <!--Add favorites icons--><!-- End favorite icons --> <!-- render the required CSS and JS in the head section --> <!-- loadCSS function header.jsp--> <! ...

Golar LNG, a Bermuda-based liquefied natural gas (LNG) company, has begun a formal strategic review to examine options that advance its floating liquefied natural gas (FLNG) expansion and maximise shareholder value. The company’s Board of Directors stated that the evaluation will encompass Golar’s FLNG technology, existing long-term contracts and future growth opportunities. As part of this process, Golar LNG has engaged Goldman Sachs International as its financial adviser. The purpose of the strategic ...

Contends Driven Brands is Undervalued by the Public Markets due to Structural, Capital Allocation, and Governance Failures  Believes That Strategic Process Will Maximize Value for All Shareholders Believes Shareholders Can Fetch in Excess of $30 a Share in a Controlled Sale or Breakup MIAMI BEACH, Fla., March 26, 2026 (GLOBE NEWSWIRE) -- ADW Capital Management, LLC, which owns approximately 2.5% of the Common Stock of Driven Brands Holdings Inc. (NASDAQ: DRVN) (the “Company”), issued an open letter to the C ...

MONTRÉAL, March 23, 2026 (GLOBE NEWSWIRE) -- Boralex Inc. (the "Corporation") is aware of recent statements in the media regarding a strategic review of alternatives being conducted by the Corporation. The Corporation confirms that its Board of Directors has formed a special committee to review and recommend strategic alternatives. The special committee is continuing its strategic review and there can be no assurance that such review will result in a transaction. The Corporation remains focused on its state ...

Delivery Hero Taiwan Divestment Conference Call Summary Company Overview - **Company**: Delivery Hero (OTCPK:DELH.Y) - **Event**: Taiwan Divestment Conference Call - **Date**: March 23, 2026 Key Points Industry and Company Context - Delivery Hero is undergoing a strategic review, with the divestment of its food delivery operations in Taiwan to Grab for **$600 million** in cash, marking a significant milestone in its strategy [3][2] - The Taiwan business generated a **GMV of EUR 1.5 billion** in full year 2025, accounting for approximately **3%** of the group's total GMV [5] Financial Implications - The divestment will reduce Delivery Hero's net leverage from approximately **2.7 times to 2.2 times**, strengthening its capital structure [5] - The transaction is expected to close in the **second half of 2026**, pending regulatory approvals [5] - Delivery Hero will provide support services for a migration period of up to **12 months** post-transaction [5] Operational Performance - The Taiwan business was noted to have a positive EBITDA before central costs, with the impact of its loss on overall EBITDA expected to be marginal for 2026 [14] - The company anticipates that the transition services will not significantly affect cash flow or EBITDA during the support period [14] Market Position and Competitiveness - Delivery Hero holds a strong market position in Taiwan, having improved profitability over recent years [32] - The competitive landscape includes Uber, with varying strengths in different geographical areas [32] Strategic Rationale - The divestment is part of a broader strategy to optimize the company's asset portfolio and focus on core operations [3] - The management emphasized the importance of maintaining flexibility and being prepared for future opportunities or challenges [10] Future Outlook - The company is not providing interim updates on other ongoing reviews to protect the integrity of the processes [5] - The management expressed confidence in the deal's value for both Delivery Hero and Grab, indicating a favorable market environment for the transaction [24] Additional Insights - The issuance of a **$1.4 billion** term loan prior to the divestment raised questions among investors regarding the need for such a substantial cash balance [8] - The management clarified that the term loan was aimed at repaying existing debt and strengthening the capital structure [10] This summary encapsulates the critical aspects of the Delivery Hero conference call, highlighting the strategic divestment, financial implications, operational performance, and market positioning within the food delivery industry.

Core Insights - Information Services Corporation (ISC) reported its strongest financial performance in 2025, achieving record annual revenue and adjusted EBITDA, while surpassing expectations for adjusted EBITDA and meeting long-term net leverage targets six months ahead of schedule [2][5][10]. Financial Performance - Fourth Quarter 2025 revenue was $65.5 million, a 5% increase from $62.2 million in Q4 2024, driven by strong performance in the Saskatchewan Registries division, particularly in the Land Registry [6][15]. - Annual revenue for 2025 reached $257.8 million, up 4% from $247.4 million in 2024, primarily due to strong results in the Saskatchewan Registries division [8][15]. - Adjusted EBITDA for Q4 2025 was $27.1 million, an increase from $21.0 million in Q4 2024, with an adjusted EBITDA margin of 41% compared to 34% in the prior year [6][7]. - Annual adjusted EBITDA was $103.1 million for 2025, up from $90.3 million in 2024, with an adjusted EBITDA margin of 40% [10][15]. Income and Cash Flow - Net income for Q4 2025 was $4.9 million, or $0.26 per share, down from $5.3 million or $0.29 per share in Q4 2024, attributed to increased share-based compensation expenses [6][10]. - Annual net income for 2025 was $26.8 million, or $1.44 per share, compared to $20.2 million or $1.11 per share in 2024 [10][26]. - Adjusted free cash flow for Q4 2025 was $19.2 million, up from $13.2 million in Q4 2024, driven by strong operating results [9][10]. - Annual adjusted free cash flow was $74.7 million for 2025, an increase of $18.3 million compared to $56.4 million in 2024 [10][15]. Strategic Outlook - The company anticipates continued revenue growth in 2026, projecting revenue between $273.0 million and $283.0 million, and adjusted EBITDA between $100.0 million and $107.0 million [22][18]. - The strength of the Saskatchewan economy and a buoyant residential real estate market are expected to drive growth in Registry Operations [18][22]. - In Services, revenue growth is anticipated through organic growth in Regulatory and Recovery Solutions divisions, with new customer onboarding expected to enhance adjusted EBITDA [19][22]. Strategic Review - The Board of Directors has initiated a Strategic Review to explore options for maximizing shareholder value, which may include asset sales or acquisitions [23][24]. - The review is supported by independent advisors and aims to ensure that any outcomes align with the interests of the Government of Saskatchewan, the largest shareholder [24][23].

Core Viewpoint - Aspex Management, Delivery Hero's second-largest shareholder, is pressuring the company to sell non-core assets or face potential management changes [1][4]. Group 1: Shareholder Pressure - Aspex Management holds approximately 9.2% of Delivery Hero's stock and is advocating for the sale of assets that do not align with the company's core operations [2]. - The letter from Aspex indicates skepticism among shareholders regarding the urgency and seriousness of Delivery Hero's strategic review [4]. Group 2: Financial Performance and Strategic Review - Delivery Hero is currently evaluating options to improve its finances and operations amid increasing consolidation in the food delivery industry, which operates on thin margins [3]. - The company has seen its shares decline nearly 33% over the past year, resulting in a market value of about €5 billion ($5.8 billion) [4]. Group 3: Geographic Footprint and Profitability - Aspex argues that Delivery Hero's profitability is lower than its peers due to its operations in over 70 countries, suggesting that the company should focus on fewer markets to optimize profitability [6][7]. - The expansive geographic footprint has led to significant legal provisions and contingent liabilities exceeding €1.4 billion [7]. Group 4: Management's Response - Delivery Hero's CEO, Niklas Östberg, acknowledged the dialogue with shareholders and emphasized the company's commitment to unlocking shareholder value while evaluating all strategic options with JPMorgan as advisers [5].

Core Insights - Waldencast reported FY 2025 net revenue of $272.1 million, flat compared to FY 2024, with an Adjusted EBITDA of $16.1 million, reflecting a significant decline of 60.1% year-over-year [1][22][19] - The company experienced mixed results across its portfolio in Q4 2025, with net revenue of $72.0 million, also flat compared to Q4 2024, and an Adjusted EBITDA of $6.6 million, down 41.4% year-over-year [1][11][13] - Obagi Medical showed revenue acceleration due to transformation efforts and brand momentum, while Milk Makeup maintained U.S. consumption growth despite international market softness [1][2][5] Financial Performance - For Q4 2025, Waldencast's net revenue decreased by 0.1% year-over-year to $72.0 million, with a gross profit of $48.2 million and an Adjusted Gross Profit of $51.2 million, representing a gross margin of 71.2% [11][12][14] - The net loss for Q4 2025 was $33.5 million, primarily due to financing costs related to credit facility refinancing [12][31] - For the year ended 2025, net revenue decreased by 0.7% to $272.1 million, with a gross profit of $183.0 million and an Adjusted Gross Profit margin of 71.6% [16][17][22] Brand Performance - Obagi Medical achieved a net revenue of $161.6 million in FY 2025, an increase of 8.3% from FY 2024, driven by strong international demand and U.S. direct-to-consumer success [22][15] - Milk Makeup's net revenue for FY 2025 was $110.4 million, down 11.4% year-over-year, impacted by softer international consumption despite a 6.2% growth in U.S. consumption [22][6][5] Strategic Initiatives - Waldencast advanced its strategic priorities in 2025 by entering the medical aesthetics market and enhancing financial flexibility through the sale of the Obagi Japan trademark for $82.5 million [1][8] - The company is focusing on strengthening its balance sheet and strategic focus, with a comprehensive review of strategic alternatives underway [7][8] - Obagi Medical's upcoming launch of Obagi saypha MagIQ injectables in Q1 2026 is expected to double its addressable market and solidify its leadership in integrated skincare and medical aesthetics [2][3] Liquidity and Debt Management - As of December 31, 2025, Waldencast held $30.4 million in cash and cash equivalents, with net debt totaling $121.7 million, a reduction from $154.2 million in the previous year [20][21] - The company entered into a new $225 million three-year credit facility in November 2025, utilizing proceeds from the sale of the Obagi Japan trademark to reduce debt [20][8]

Core Viewpoint - Hain Celestial has experienced a significant decline in share price, losing approximately 29.8% over the past month, underperforming the S&P 500, raising questions about the continuation of this negative trend leading up to the next earnings release [1][2]. Financial Performance - Hain Celestial reported a second-quarter fiscal 2026 loss, with both revenue and earnings declining year over year. The adjusted loss was 3 cents per share, down from adjusted earnings of 8 cents in the same quarter last year [3][4]. - Net sales reached $384.1 million, exceeding the consensus estimate of $383 million, but represented a 6.7% decline year over year. Organic net sales also fell by 7%, primarily due to a 9-point decline in volume and mix, partially offset by a 2-point benefit from pricing actions [4]. - Adjusted gross profit decreased to $74.9 million from $94.3 million in the prior-year quarter, with the adjusted gross margin contracting 340 basis points to 19.5% due to cost inflation and lower volume [5]. Expense Management - Selling, General and Administrative (SG&A) expenses were $60.9 million, down 13.2% from $70.2 million in the previous year, reflecting lower employee-related expenses and disciplined cost management [6]. - Adjusted EBITDA was $24.3 million, a decline of 35.9% from $37.9 million in the prior-year quarter, with the adjusted EBITDA margin decreasing 290 basis points to 6.3% [7]. Segment Performance - In the North America segment, net sales dropped 13.7% year over year to $197.8 million, with organic net sales declining 10.3% due to weakness in snacks and baby formula [8]. - The International segment saw net sales of $186.3 million, marking a year-over-year increase of 2.3%, although organic net sales slipped 2.7% [11]. Cash Flow and Financial Position - The company ended the quarter with cash and cash equivalents of $68 million and long-term debt of $0.4 million. Net cash provided by operating activities was $37 million, up from $30.9 million in the prior-year period [15]. - Free cash flow for the quarter was an inflow of $30 million compared to $24.5 million in the previous year, with capital expenditures totaling $7 million [16]. Strategic Outlook - Hain Celestial is not providing numeric guidance for fiscal 2026 due to uncertainties regarding the strategic review and the expected divestiture of the North American Snacks business, which is anticipated to be gross margin and EBITDA-accretive [17]. - The company aims to strengthen its financial position through initiatives to stabilize sales, improve profitability, and optimize cash flow, with expectations of positive free cash flow for fiscal 2026 [19]. Market Sentiment - Recent estimates for Hain Celestial have trended downward, with a consensus estimate shift of -133.33% [20]. - The company holds a Zacks Rank 3 (Hold), indicating expectations of an in-line return from the stock in the coming months [23].

Q4 2025 Earnings Presentation February 25, 2026 Disclaimer Forward-Looking Statements & Non-GAAP Financial Measures The matters discussed in this presentation, particularly those in the section labeled "Guidance," include forward-looking statements regarding, among other things, future operating results. When used in this presentation, the words "outlook," "intends to," "believes," "anticipates," "expects," "achieves," "estimates," and similar expressions are intended to identify forward-looking statements. ...